These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8797211)

  • 1. [Case report of sodium valproate treatment of aggression associated with Alzheimer's disease].
    Takahashi M; Akagi M
    No To Shinkei; 1996 Aug; 48(8):757-60. PubMed ID: 8797211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticonvulsants in agitation and behavior disorders in demented subjects. Report of 8 cases].
    Fahs H; Potiron G; Senon JL; Perivier E
    Encephale; 1999; 25(2):169-74. PubMed ID: 10370890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproate-induced delirium in a demented patient.
    Gareri P; Lacava R; Cotroneo A; Bambara V; Marigliano N; Castagna A; Costantino DS; Ruotolo G; de Sarro G
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():113-8. PubMed ID: 19836623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A placebo-controlled trial of valproate for agitation and aggression in Alzheimer's disease.
    Herrmann N; Lanctôt KL; Rothenburg LS; Eryavec G
    Dement Geriatr Cogn Disord; 2007; 23(2):116-9. PubMed ID: 17148938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and management of aggressive behavior in the elderly demented patient.
    Raskind MA
    J Clin Psychiatry; 1999; 60 Suppl 15():45-9. PubMed ID: 10418815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report on an open-label prospective study of divalproex sodium for the behavioral and psychological symptoms of dementia as monotherapy and in combination with second-generation antipsychotic medication.
    Forester B; Vanelli M; Hyde J; Perez R; Ahokpossi C; Sribney W; Adkison L
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):209-17. PubMed ID: 17996660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probable valproate sodium-associated hypotension.
    Ota KS
    Am J Geriatr Pharmacother; 2010 Jun; 8(3):281-4. PubMed ID: 20624617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
    De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
    Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of anticonvulsants in treating agitated demented elderly patients.
    Grossman F
    Pharmacotherapy; 1998; 18(3):600-6. PubMed ID: 9620110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose propranolol reduces aggression and agitation resembling that associated with orbitofrontal dysfunction in elderly demented patients.
    Shankle WR; Nielson KA; Cotman CW
    Alzheimer Dis Assoc Disord; 1995; 9(4):233-7. PubMed ID: 8749613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate in the treatment of aggressive behavior in patients with dementia--a randomized placebo controlled clinical trial.
    Sival RC; Haffmans PM; Jansen PA; Duursma SA; Eikelenboom P
    Int J Geriatr Psychiatry; 2002 Jun; 17(6):579-85. PubMed ID: 12112183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of anticonvulsants in the treatment of impulsive aggression.
    Stanford MS; Helfritz LE; Conklin SM; Villemarette-Pittman NR; Greve KW; Adams D; Houston RJ
    Exp Clin Psychopharmacol; 2005 Feb; 13(1):72-7. PubMed ID: 15727506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium valproate in aggressive behaviour in dementia: a twelve-week open label follow-up study.
    Sival RC; Duivenvoorden HJ; Jansen PA; Haffmans PM; Duursma SA; Eikelenboom P
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):305-12. PubMed ID: 15065222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of sodium valproate on aggressive behavior of male mice with various aggression experience].
    Smagin DA; Bondar' NP; Kudriavtseva NN
    Eksp Klin Farmakol; 2010 Jan; 73(1):10-5. PubMed ID: 20184281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium valproate in the treatment of behavioral disturbance in dementia.
    Mellow AM; Solano-Lopez C; Davis S
    J Geriatr Psychiatry Neurol; 1993; 6(4):205-9. PubMed ID: 8251047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproate use in neuropsychiatric disorders in the elderly.
    Tariot PN
    Psychopharmacol Bull; 2003; 37 Suppl 2():116-28. PubMed ID: 15021866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Frontal dementia or dementia praecox? A case report of a psychotic disorder with a severe decline].
    Vanderzeypen F; Bier JC; Genevrois C; Mendlewicz J; Lotstra F
    Encephale; 2003; 29(2):172-80. PubMed ID: 14567169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An 84-year-old woman with progressive mental deterioration and abnormal behavior].
    Kanazawa A; Ikebe S; Komatsuzaki Y; Takanashi M; Mori H; Mochizuki H; Mizuno Y
    No To Shinkei; 2001 Feb; 53(2):199-209. PubMed ID: 11277107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delusional misidentification and aggression in Alzheimer's disease.
    Silva JA; Leong GB; Weinstock R; Ruiz-Sweeney M
    J Forensic Sci; 2001 May; 46(3):581-5. PubMed ID: 11372992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.